WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
www.gsk.com
GlaxoSmithKline RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category GlaxoSmithKline
Title
Published Date
GSK applies for licence to market OTC weight loss product In Europe
03 October 2007
GlaxoSmithKline receives approval for Atriance® (nelarabine) in Europe
07 September 2007
GlaxoSmithKline Signs Contract for its Pandemic Flu Vaccine with UK Government
16 August 2007
Start
Prev
14
15
16
17
18
19
20
21
22
23
Next
End
Business & Industry
Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
Bayer Consumer Health leaders propose new principles for science-led self-care
GSK signs agreement to support pandemic preparedness in Europe
Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager
Research & Development
Treating cancer by sticking cells in place
Vitamin K prevents cell death: a new function for a long-known molecule
Disparities in United States COVID-19 vaccine distribution
New needle-free nasal vaccine shows promise for COVID-19
Scientists develop new biomimetic formulation for treating glioblastoma
SARS-CoV-2 hijacks nanotubes between neurons to infect them
Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants
Conferences & Events
New approach to treatment of deadly kidney cancer
SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
SMi's 22nd Annual Pain Therapeutics Conference
SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
FDA approves first systemic treatment for alopecia areata
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
FDA limits use of Janssen COVID-19 vaccine to certain individuals
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
FDA approves first generic of Symbicort to treat asthma and COPD
You are here:
Home
GlaxoSmithKline